Get started
Author

Pablo Pérez-Galindo

Observed names: P Pérez-Galindo, Pablo Perez-Galindo, Pérez-Galindo, Pablo
ORCID: 0000-0002-4182-0254
Observed ORCID: 0000-0002-4182-0254
OpenAlex ID: A5000889870
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
2022 · Laurent Peyrin-Biroulet, Jean-François Rahier, et al. · Clinical Gastroenterology and Hepatology · 42
PDF
Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu
2021 · María José García, Montserrat Rivero, et al. · Journal of Clinical Medicine · 22
The Impact of COVID-19 on Patients with IBD in a Prospective European Cohort Study
2022 · Aurelien Amiot, Jean-Francois Rahier, et al. · Journal of Crohn s and Colitis · 18
PDF
Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA Registry
2026 · Pablo Pérez-Galindo, Javier P Gisbert, et al. · Journal of Crohn s and Colitis · 4
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
2024 · Margalida Calafat, Paola Torres, et al. · Therapeutic Advances in Gastroenterology · 1
PDF
Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU
2026 · Inmaculada Alonso-Abreu, Laura Ramos, et al. · Therapeutic Advances in Gastroenterology
Esophageal, gastric and duodenal Crohn’s disease in the biologic era: Results from a retrospective observational nationwide study of GETECCU
2026 · Alicia López-García, Cristina Suárez Ferrer, et al. · Digestive and Liver Disease
PDF
P211 Impact of celiac disease on the outcome of Inflammatory Bowel Disease
2024 · I Alonso, L Ramos, et al. · Journal of Crohn s and Colitis
PDF
45 - Impacto Del Tratamiento Oncológico En La Evolución De La Enfermedad Inflamatoria Intestinal (estudio Oncoeii De Geteccu)
2023 · Pablo Pérez-Galindo, Jose Manuel Benítez, et al. · Gastroenterología y Hepatología
46 - Características De La Afectación Esofagogastroduodenal De La Enfermedad De Crohn En La Era Biológica: Estudio Multicéntrico Del Grupo Joven De Geteccu
2023 · Alicia López-García, José Manuel Benítez, et al. · Gastroenterología y Hepatología
P550 Long-term effectiveness of anti-TNF agents in symptomatic stricturing Crohn’s disease
2020 · I Rodríguez-Lago, J Del Hoyo, et al. · Journal of Crohn s and Colitis
PDF
P223 Efficacy and safety of tacrolimus in Crohn’s disease: a nationwide, multi-centric study from GETECCU
2019 · I Rodriguez-Lago, J Castro-Poceiro, et al. · Journal of Crohn s and Colitis
DOP44 Efficacy and safety of tacrolimus in ulcerative colitis: a nationwide, multi-centre study from GETECCU
2019 · I Rodriguez-Lago, J Castro-Poceiro, et al. · Journal of Crohn s and Colitis
Works count: 17
Citation count: 87
H-index: 4
I10-index: 3
Year
Topic
Type